Body

Anyone who has squashed a stink bug knows why they got their name. Although just a nuisance to homeowners, the insects feed on and damage fruits and vegetables, causing significant economic losses for farmers. Now scientists report in ACS' Journal of Natural Products that they've discovered certain stink bug pheromone components and made them artificially in the lab for the first time, and these substances can be used to monitor and manage their populations.

Rochester, Minn. — An abdominal aortic aneurysm is a potentially life-threatening condition: If the body's major blood vessel ruptures, it can prove deadly. The U.S. Preventive Services Task Force recently updated its recommendations on screening. Mayo Clinic vascular surgeon Peter Gloviczki, M.D., explains who should be watched for abdominal aortic aneurysms, how they are diagnosed and how surgery, which now includes a less invasive endovascular option, is improving survival rates:

MULTIMEDIA ALERT: Video and audio are available for download on the Mayo Clinic News Network.

OAK RIDGE, Tenn., July 16, 2014 -- Neutron scattering research at the Department of Energy's Oak Ridge National Laboratory has revealed clear structural differences in the normal and pathological forms of a protein involved in Huntington's disease.

Huntington's disease, an incurable neurodegenerative disorder, starts as a genetic mutation that leads to an overabundance of "huntingtin" protein fragments, which form clumps in the brain.

CHICAGO (July 16, 2014) – Expert guidance released today offers updated evidence reviews and recommendations for hand hygiene in healthcare facilities. The guidance is featured in the August issue of Infection Control and Hospital Epidemiology and emphasizes best practices for implementing and optimizing hand hygiene programs to prevent the spread of healthcare-associated infections (HAIs).

A cancer drug that has shown promise against Alzheimer's disease in mice and has begun early clinical trials has yielded perplexing results in a novel mouse model of AD that mimics the genetics and pathology of the human disease more closely than any other animal model.

The drug, bexarotene, was found to reduce levels of the neurotoxic protein amyloid-beta in experimental mice with late-stage Alzheimer's but to increase levels during early stages of disease.

If you've ever tried to watch a video on a tablet on a sunny day, you know you have to tilt it at just the right angle to get rid of glare or invest in a special filter. But now scientists are reporting in the journal ACS Applied Materials & Interfaces that they've developed a novel glass surface that reduces both glare and reflection, which continue to plague even the best mobile displays today.

DETROIT — Researchers at Wayne State University have made a fundamental discovery and, in subsequent collaboration with scientists at La Jolla Institute for Allergy and Immunology (LIAI), are one step closer to the goal of developing the world's first T-cell peptide-based vaccine for heart disease — the number one killer in the nation.

A new protein biomarker test platform developed by researchers at the University of Michigan and Indiana University promises to improve diagnostic testing. The test can accurately and simultaneously measure multiple proteins that indicate the presence of diseases like graft-versus-host disease (bone marrow transplant rejection) in only two hours, no washing steps, and using only a minute volume of blood plasma. A report on this new technology can be found online in the journal TECHNOLOGY.

On 16 July 2014 the German Institute for Quality and Efficiency in Health Care (IQWiG) published the results of a literature search for evidence-based clinical practice guidelines on the treatment of people with breast cancer. The aim of the report is to identify those recommendations from current guidelines of high methodological quality that may be relevant for the planned revision of the disease management programme (DMP). According to the results of the report, there is no compelling need for revision of any part of the DMP.

Scientists have designed a new self-assembling nanoparticle that targets tumours, to help doctors diagnose cancer earlier.

The new nanoparticle, developed by researchers at Imperial College London, boosts the effectiveness of Magnetic Resonance Imaging (MRI) scanning by specifically seeking out receptors that are found in cancerous cells.

Scientists now have a better understanding of how short DNA strands decompose in microseconds. A European team found new fragmentation pathways that occur universally when DNA strands are exposed to metal ions from a family of alkaline and alkaline earth elements. These ions tend to replace protons in the DNA backbone and at the same time induce a reactive conformation leading more readily to fragmentation. These findings by Andreas Piekarczyk, from the University of Iceland, and colleagues have been published in a study in EPJ D.

University of Leicester researchers have released evidence substantiating an unexpected dual role of an important component of the immune system.

Findings by researchers at the University's Department of Infection, Immunity and Inflammation – including three PhD graduates – are published in a paper for the journal 'Medical Microbiology and Immunology'.

Scientists have discovered a new pathway the dengue virus takes to suppress the human immune system. This new knowledge deepens our understanding of the virus and could contribute to the development of more effective therapeutics.

For years, the conventional approach to target the dengue virus was through vector control, which was regarded to be the most effective method. This is because the mechanics of the virus have been elusive, which in turn hampered the development of effective treatments and vaccines.

People who selflessly step up and donate a kidney can face insurance challenges afterwards, despite the lack of evidence that they have increased health risks. The finding, which comes from a new study published in the American Journal of Transplantation, suggests that actions by insurers may create unnecessary burden and stress for those choosing to donate and could negatively impact the likelihood of live kidney donation.

Healthy living kidney donors often face pointless post-donation hurdles when seeking or changing health or life insurance, according to results of a new study by Johns Hopkins researchers.

"Living donors are some of the healthiest people in the United States. They're heavily screened before they're approved for donation and should be easily insurable," says study leader Dorry Segev, M.D., Ph.D., M.H.S., an associate professor of surgery and epidemiology at The Johns Hopkins University.